PHARMACIST INTERVENTIONS: THE SUCCESS OF AN ANTIMICROBIAL STEWARDSHIP TEAM
4CPS-194
CLINICAL IMPACT OF GENOMIC BIOMARKERS PREDICTORS OF RESPONSE AND THE THERAPEUTIC STRATEGY IN PATIENTS WITH MYELODYSPLASTIC SYNDROME ASSOCIATED WITH DEL
4CPS-193
A THEORETICALLY BASED CROSS-SECTIONAL SURVEY ON THE BEHAVIOURS AND EXPERIENCES OF CLINICAL PHARMACISTS CARING FOR CHRONIC KIDNEY DISEASE PATIENTS
4CPS-192
IDENTIFYING MEDICATION HISTORY ERRORS AT HOSPITAL ADMISSION USING THE LUND INTEGRATED MEDICINES MANAGEMENT MODEL
4CPS-191
EFFECTIVENESS AND SAFETY OF RADIUM-223 CHLORIDE IN BONE-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
4CPS-190
RITUXIMAB USE IN CHILDREN, A SINGLE HOSPITAL EXPERIENCE
4CPS-189
ADEQUACY OF THE PRESCRIPTION OF PARENTERAL NUTRITION IN NEONATOLOGY
4CPS-188
GALENIC PREPARATIONS AND RARE DISEASES: GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY: EXPERIENCE IN A LOCAL HOSPITAL
4CPS-187
EVALUATION OF EXIT PRESCRIPTIONS USING COMPUTERISED PROVIDER ORDER-ENTRY SYSTEM FOR OUTPATIENTS
4CPS-186
THERAPEUTIC DRUG MONITORING OF TYROSINE KINASE INHIBITORS: KEY TO PERSONALISED MEDICINE IN ONCOLOGY
4CPS-185
THE EFFECTIVENESS OF ENZYME REPLACEMENT THERAPY IN THE MANAGEMENT OF GAUCHER DISEASE
4CPS-184
OFF-LABEL USES OF BEVACIZUMAB IN OPHTHALMOLOGY IN A MOROCCAN UNIVERSITY HOSPITAL
4CPS-183
COLLABORATION WITH THE OPHTHALMOLOGY SERVICE IN A PUBLIC RESIDENTIAL CARE HOME
4CPS-182
EXPERIENCE WITH OMALIZUMAB IN THE TREATMENT OF UNCONTROLLED PERSISTENT ASTHMA
